Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.

[1]  J. Bouwstra,et al.  In vivo assessment of safety of microneedle arrays in human skin. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  S. Mitragotri,et al.  Low-frequency sonophoresis: current status and future prospects. , 2008, Advanced drug delivery reviews.

[3]  H. Dupont,et al.  Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial , 2008, The Lancet.

[4]  J. Bouwstra,et al.  Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[5]  G. Glenn,et al.  Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch , 2007, Expert review of vaccines.

[6]  Zhu Guo,et al.  Needle-Free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection against Lethal Challenge in Mice , 2007, Clinical and Vaccine Immunology.

[7]  J. Bouwstra,et al.  Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Vincent J. Sullivan,et al.  Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine , 2006, Infection and Immunity.

[9]  R. Compans,et al.  Transcutaneous immunization with inactivated influenza virus induces protective immune responses. , 2006, Vaccine.

[10]  P. Upadhyay.  Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia. , 2006, Vaccine.

[11]  Ulrike Blume-Peytavi,et al.  40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. , 2006, The Journal of investigative dermatology.

[12]  M. Cormier,et al.  Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. , 2006, Vaccine.

[13]  S W Hui,et al.  Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. , 2006, Vaccine.

[14]  G. Glenn,et al.  Mass vaccination: solutions in the skin. , 2006, Current topics in microbiology and immunology.

[15]  S. Muller,et al.  Effect of Skin Barrier Disruption on Immune Responses to Topically Applied Cross-Reacting Material, CRM197, of Diphtheria Toxin , 2005, Infection and Immunity.

[16]  Cheryl H. Dean,et al.  Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates , 2005, Human vaccines.

[17]  A. Rawat,et al.  Tetanus toxoid‐loaded transfersomes for topical immunization , 2005, The Journal of pharmacy and pharmacology.

[18]  Vincent J. Sullivan,et al.  Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. , 2005, The Journal of infectious diseases.

[19]  G. Glenn,et al.  Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. , 2005, Vaccine.

[20]  G. Glenn,et al.  Induction of protective immunity against lethal anthrax challenge with a patch. , 2004, The Journal of infectious diseases.

[21]  Dexiang Chen,et al.  Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. , 2004, Virus research.

[22]  J. Lademann,et al.  Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.

[23]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[24]  W. Hennink,et al.  Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. , 2003, Vaccine.

[25]  G. Glenn,et al.  Transcutaneous immunization and immunostimulant strategies. , 2003, Immunology and allergy clinics of North America.

[26]  R. Rappuoli,et al.  Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses. , 2003, The Journal of infectious diseases.

[27]  Diane E. Sutter,et al.  Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.

[28]  J. Wilschut,et al.  Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. , 2001, Vaccine.

[29]  C. Alving,et al.  Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants , 2000, Infection and Immunity.

[30]  J. Bos,et al.  The 500 Dalton rule for the skin penetration of chemical compounds and drugs , 2000, Experimental dermatology.

[31]  C. Alving,et al.  Principles of transcutaneous immunization using cholera toxin as an adjuvant. , 1999, Vaccine.

[32]  J. Wilschut,et al.  Musosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen , 1998 .

[33]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[34]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[35]  G. Matyas,et al.  Skin immunization made possible by cholera toxin , 1998, Nature.

[36]  K. Miyamura,et al.  Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. , 1974, Journal of biological standardization.